Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

The treatment of patients with chronic myeloid leukemia chronic phase combined with myelofibrosis with tyrosine kinase inhibitors: A Chinese population-based study.

View Full Paper
Ask AI
Bookmark
Share

Authors

XZXinlu ZhangCentral South University of Forestry and TechnologyXYXiudi YangPrecision for Medicine (United States)DCDan ChenZhejiang Chinese Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e671b5b6db6435875fbce5https://doi.org/10.1200/jco.2024.42.16_suppl.e18524
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Prevalence and Clinical Impact of Bone Marrow Fibrosis in Chronic Myeloid Leukemia2026
  2. 2Primary Myelofibrosis ( <scp>PMF</scp> )—The German <scp>ONKOPEDIA</scp> Guideline 20252026
  3. 3Clinico-hematological characteristic, lipogram, and some metabolic alteration in chronic phase chronic myeloid leukemia in a patient treated with Tyrosine kinase inhibitor2026
  4. 4Outcomes of patients with bone marrow fibrosis in de novo and secondary acute myeloid leukemia.2024
  5. 5Impact of leukocytosis on outcomes in patients with myelofibrosis: A propensity-matched analysis.2026